|
InspraDrug - Inspra The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Eplerenone
Strength -
100MG
Applicant -
GD SEARLE LLC
New Drug Application (NDA) Number -
021437
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 27, 2002
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Gd Searle Llc
Inspra
Lidosite Topical System Kit 1.05mg/patch;100mg/patch Patch; Iontophoresis
Iontocaine 0.01mg/ml;2% Solution; Iontophoresis Lidocaine Hcl And Epinephrine 0.01mg/ml;2% Solution; Iontophoresis Procaine Hcl W/ Epinephrine 0.02mg/ml;1% Injectable; Injection Procaine Hcl W/ Epinephrine 0.02mg/ml;2% Injectable; Injection Ellence 2mg/ml Injectable; Injection Inspra 100mg Tablet; Oral Xylocaine W/ Epinephrine 0.02mg/ml;2% Injectable; Injection Xylocaine W/ Epinephrine 0.01mg/ml;2% Injectable; Injection Xylocaine W/ Epinephrine 0.02mg/ml;2% Injectable; Injection NewDrugInformation |